Filing Flows

Filing Flows › AdaptHealth (AHCO) › Q3 2026

AdaptHealth (AHCO) Q3 2026 earnings results (third quarter 2026)

10-Q filed Nov 3, 2026

AdaptHealth (AHCO) reported revenue of $746M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +0.7% from the quarter before. Operating margin was -20.9%, net loss $153M (20.5% of revenue).

Revenue$746M
Year over year+11%
Quarter over quarter+0.7%
Operating margin-20.9%
Net earnings−$153M

AdaptHealth, Q3 2026: revenue $746M (+11% year over year), operating margin -20.9%, net loss $153M, operating cash flow $157M. The chart follows the revenue to costs, profit and cash.

Q3 2026AmountQ/QY/Y
Revenue$746M+0.7%+11%
Operating profit−$156M—-353%
Net earnings−$153M—-723%
Operating cash flow$157M+8%-3%
Free cash flow$51.1M—-24%

What changed

Revenue was $745.6M in Q3 2026, up 11% year over year and up 1% from the previous quarter. Sleep Health was the largest line at 53% of revenue. Sleep Health added $39.0M year over year (up 11%), 53% of the total change.

Operating costs exceeded revenue by $155.9M, an operating margin of -20.9%. Total costs grew 43% against revenue growth of 11%. The fastest-growing cost line was Other operating costs (+2500%). The quarter ended with a net loss of $152.8M, wider than the previous quarter's $132.7M loss.

Operating cash flow was $156.6M (down 3% year over year). Non-cash charges added back $116.9M of depreciation and amortization and $1.2M of share-based compensation. Working capital and other items added $191.3M. After purchases of equipment and other fixed assets ($105.5M), free cash flow as the company reports it was $51.1M.

Questions

What was AdaptHealth's revenue in the third quarter 2026?

AdaptHealth (AHCO) reported revenue of $746M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +0.7% from the quarter before.

Was AdaptHealth profitable in the third quarter 2026?

Operating loss was $156M (-20.9% of revenue) and net loss $153M.

Open the interactive Sankey →

Source: AdaptHealth 10-Q on SEC EDGAR.